Royal Bank of Canada
MDT icon

Royal Bank of Canada’s Medtronic MDT Stock Holding History

Royal Bank of Canada’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23B Buy
14,179,817
+190,987
+1% +$18.3M 0.22% 83
2025
Q4 		$1.34B Sell
13,988,830
-248,366
-2% -$24.1M 0.22% 84
2025
Q3 		$1.36B Buy
14,237,196
+3,097,969
+28% +$285M 0.22% 81
2025
Q2 		$971M Sell
11,139,227
-1,422,675
-11% -$121M 0.18% 107
2025
Q1 		$1.13B Sell
12,561,902
-491,834
-4% -$44M 0.24% 88
2024
Q4 		$1.04B Buy
13,053,736
+1,374,242
+12% +$119M 0.21% 98
2024
Q3 		$1.05B Buy
11,679,494
+268,874
+2% +$22.6M 0.21% 90
2024
Q2 		$898M Sell
11,410,620
-1,476,942
-11% -$121M 0.2% 90
2024
Q1 		$1.12B Buy
12,887,562
+255,261
+2% +$21.8M 0.26% 83
2023
Q4 		$1.04B Sell
12,632,301
-634,804
-5% -$48.4M 0.24% 85
2023
Q3 		$1.04B Sell
13,267,105
-43,288
-0.3% -$3.62M 0.28% 78
2023
Q2 		$1.17B Buy
13,310,393
+518,485
+4% +$44.6M 0.31% 70
2023
Q1 		$1.03B Buy
12,791,908
+205,663
+2% +$16.8M 0.29% 71
2022
Q4 		$978M Sell
12,586,245
-1,115,978
-8% -$90.4M 0.28% 76
2022
Q3 		$1.11B Buy
13,702,223
+608,587
+5% +$54.7M 0.35% 61
2022
Q2 		$1.18B Buy
13,093,636
+288,585
+2% +$29.2M 0.35% 61
2022
Q1 		$1.42B Buy
12,805,051
+692,864
+6% +$73.2M 0.36% 54
2021
Q4 		$1.25B Sell
12,112,187
-164,200
-1% -$19M 0.29% 75
2021
Q3 		$1.54B Buy
12,276,387
+371,537
+3% +$48.1M 0.41% 47
2021
Q2 		$1.48B Buy
11,904,850
+527,442
+5% +$66.2M 0.39% 49
2021
Q1 		$1.34B Buy
11,377,408
+577,928
+5% +$67.7M 0.39% 48
2020
Q4 		$1.27B Buy
10,799,480
+792,586
+8% +$87.3M 0.37% 55
2020
Q3 		$1.04B Buy
10,006,894
+412,679
+4% +$41.4M 0.37% 55
2020
Q2 		$880M Sell
9,594,215
-332,478
-3% -$31.9M 0.35% 65
2020
Q1 		$895M Buy
9,926,693
+889,774
+10% +$94.7M 0.43% 47
2019
Q4 		$1.03B Buy
9,036,919
+254,782
+3% +$28M 0.37% 57
2019
Q3 		$954M Sell
8,782,137
-99,543
-1% -$10.4M 0.38% 56
2019
Q2 		$865M Buy
8,881,680
+446,285
+5% +$40.7M 0.35% 58
2019
Q1 		$768M Buy
8,435,395
+476,786
+6% +$42.7M 0.33% 67
2018
Q4 		$724M Buy
7,958,609
+632,591
+9% +$59.1M 0.35% 59
2018
Q3 		$723M Buy
7,326,018
+209,809
+3% +$19.4M 0.3% 69
2018
Q2 		$609M Sell
7,116,209
-52,287
-0.7% -$4.37M 0.27% 74
2018
Q1 		$575M Buy
7,168,496
+299,486
+4% +$24.7M 0.26% 72
2017
Q4 		$555M Buy
6,869,010
+249,517
+4% +$20M 0.24% 82
2017
Q3 		$515M Buy
6,619,493
+280,406
+4% +$23.3M 0.25% 79
2017
Q2 		$563M Buy
6,339,087
+314,187
+5% +$26.5M 0.29% 66
2017
Q1 		$485M Sell
6,024,900
-877,635
-13% -$68.6M 0.26% 74
2016
Q4 		$492M Buy
6,902,535
+453,336
+7% +$35.6M 0.27% 65
2016
Q3 		$557M Sell
6,449,199
-127,555
-2% -$11.1M 0.31% 55
2016
Q2 		$571M Buy
6,576,754
+890,502
+16% +$72M 0.34% 50
2016
Q1 		$426M Buy
5,686,252
+911,971
+19% +$68.7M 0.27% 69
2015
Q4 		$367M Buy
4,774,281
+162,574
+4% +$12.2M 0.24% 77
2015
Q3 		$309M Buy
4,611,707
+299,530
+7% +$22.1M 0.23% 69
2015
Q2 		$320M Buy
4,312,177
+871,905
+25% +$66.6M 0.22% 71
2015
Q1 		$268M Sell
3,440,272
-35,576
-1% -$2.7M 0.19% 82
2014
Q4 		$251M Buy
3,475,848
+782,950
+29% +$54.4M 0.16% 95
2014
Q3 		$167M Buy
2,692,898
+595,128
+28% +$37.8M 0.11% 134
2014
Q2 		$134M Buy
2,097,770
+11,366
+0.5% +$690K 0.09% 167
2014
Q1 		$128M Buy
2,086,404
+876,662
+72% +$51.1M 0.09% 154
2013
Q4 		$69.4M Buy
1,209,742
+20,548
+2% +$1.17M 0.05% 289
2013
Q3 		$63.3M Sell
1,189,194
-286,457
-19% -$15.4M 0.05% 284
2013
Q2 		$76M Buy
+1,475,651
New +$72.9M 0.06% 217

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada's MDT Position: Q1 2026 in Review

Royal Bank of Canada increased its Medtronic (MDT) stake by 1.4% in Q1 2026, buying an estimated $18.3M and bringing the position to 14,179,817 shares worth $1.23B. The position accounts for 0.22% of the portfolio, ranked #83.

Royal Bank of Canada first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.54B in Q3 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Royal Bank of Canada held 14,179,817 shares of Medtronic worth $1.23B as of Q1 2026.
  • Royal Bank of Canada bought 190,987 Medtronic shares in Q1 2026, an estimated $18.3M.
  • Medtronic made up 0.22% of Royal Bank of Canada's portfolio in Q1 2026, its #83 holding.
  • Royal Bank of Canada first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Medtronic position peaked at $1.54B in Q3 2021.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.